Clinical trial design

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

This week in drug discovery (6-10 March)

News round-up for 6-10 March by DDW Digital Content Editor Diana Spencer.  Perhaps most interestingly this week, after previous caution over in vivo gene therapy trials, the FDA has given the go ahead to Intellia Therapeutics to study NTLA-2002 in hereditary angioedema (HAE).  There have been several… Read More

#News

Clinical trial
#Clinical trial design #Clinical trials #Collaboration #Duke Clinical Research Institute #Partnership #Protas

Research organisations partner to transform clinical trials

The Duke Clinical Research Institute (DCRI) and Protas, led by Oxford University clinical trialist Professor Sir Martin Landray, will collaborate to develop new approaches to large randomised clinical trials.  Through the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and… Read More

#News

Female doctor analysing liquid in test tube
#Clinical trial design #Clinical trials #Evoke Galliard #Sponsored content

Overcoming the blocks to successful clinical trials

This article is sponsored by Evoke. Dominic Elliston, Managing Director of Evoke Galliard and Evoke Incisive Health, shares his take on how effective clinical trial communications is the key to expediting the delivery of new and extraordinary treatments. Tell us about yourself, Dominic. My name is Dominic – most people… Read More

#Exclusive Content

#Breast cancer #Cancer research #Clinical trial design #Clinical trials #Drug development #Drug discovery #Oncology #Phase III trial

This week in drug discovery (6-10 February)

News round-up for 6-10 February by DDW Digital Content Editor Diana Spencer.  Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient… Read More

#News

Diversity
#Clinical research #Clinical trial design #Clinical trials #Diversity #Epidemiology #GSK #United States

Study shines a light on representation in clinical research

A diversity study has shown that clinical trials should use real world diseases epidemiology data, rather than US Census Bureau race and ethnicity data, to ensure enrolment reflects the populations affected by different diseases.  GSK’s retrospective study looked at clinical trial demographic data from 495 GSK and… Read More

#Editor's Choice #News

#Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials

Choosing the right site solution for clinical trials

Listen to this article on the DDW podcast: Independent Medical Writer Leonie Onslow explores the challenges of traditional clinical trial models and how to improve recruitment and retention. Covid-19 and the subsequent strain on health systems and research capabilities has created the opportunity to change the traditional clinical trial model of… Read More

#Exclusive Content

#Clinical trial design #Clinical trials #Decentralised clinical trials

What are the opportunities for decentralised clinical trials?

Listen to this article on the DDW podcast: Tom Brazier, Director, Decentralised Clinical Solutions, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. Hybrid and decentralised clinical trials (DCTs) are fast becoming the norm, but… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Clinical trial design #Funding #Psychedelics #Start-ups

What will the 2023 drug discovery landscape look like?

Listen to this article on the DDW podcast: DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry,… Read More

#Exclusive Content #Trends & Analysis

Year change from 2022 to 2023
#Clinical trial #Clinical trial design #Covid-19 #Drug delivery #Drug development #Healthcare

Drug discovery predictions: Analysis and insight 

In January 2022, DDW’s Megan Thomas spoke to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector. As we head into 2023, DDW will be publishing a series of reflections on these predictions. Here, Thomas reflects specifically on Anita Cooper’s prediction relating to… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Decentralised clinical trials #Patient centricity

Covid-related changes to clinical trials here to stay

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The… Read More

#Covid-19 #News

A clinical trial
#APAC #Clinical research #Clinical trial design #Clinical trials #Drug development

Cytel hopes to accelerate drug development in APAC region

Cytel has expanded its operations into the Asia-Pacific region (APAC), with hopes of optimising clinical trial design in the area. Cytel works with its clients on various aspects of clinical trials, including statistical design, implementation and regulatory acceptance, with the aim of helping them reduce costs, shorten timelines, and better… Read More

#News